Objectives Multiple system atrophy (MSA) is a refractory neurodegenerative disease, but novel treatments are anticipated. An accurate natural history of MSA is important for clinical trials, but is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback